President Donald Trump has signed an executive order aimed at lowering drug prices for Americans in a move that would shake up the pharmaceutical industry in its biggest and most profitable market.
The order stops short of implementing a “most favoured nation” status, which would force drugmakers to offer their lowest prices in the world to the US. Trump has previously railed against other countries for “freeloading” on US consumers, saying that American patients are subsidising medicines that are cheaper abroad.
But a US official said on Tuesday that the government was “very focused on narrowing the delta between what the United States gets for prices versus what other developed nations do”.
您已阅读23%（699字），剩余77%（2321字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。